Back
LyondellBasell Industries NV Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison
Sell
30
LYB
LyondellBasell Industries NV
Last Price:
$44.91
Seasonality Move:
5.17%
Sell
50
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$26.47
Seasonality Move:
2.66%
Sell
30
LyondellBasell Industries NV (LYB)
is a Sell
Is LyondellBasell Industries NV a Buy, Sell or Hold?
-
The current LyondellBasell Industries NV [LYB] share price is $44.91. The Score for LYB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
LYB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Apellis Pharmaceuticals, Inc. (APLS)
is a Sell
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $26.49. The Score for APLS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYB Stock Price Chart
What is LyondellBasell Industries NV's stock price today?
-
The LyondellBasell Industries NV share price today is $44.91The current trend is relatively stagnant and LYB is experiencing slight selling pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $26.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 52.7 | Buy |
| Chaikin Money Flow: | -1452952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.7 - 45.32) | Buy |
| Bollinger Bands (100): | (43.48 - 52.48) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 62.34 | Buy |
| Chaikin Money Flow: | 2954054 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.84 - 25.7) | Buy |
| Bollinger Bands (100): | (21.4 - 27.16) | Buy |
LYB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.34 | Buy |
| 20-day SMA: | 43.88 | Buy |
| 50-day SMA: | 44.62 | Buy |
| 200-day SMA: | 53.63 | Sell |
| 8-day EMA: | 44.61 | Buy |
| 20-day EMA: | 44.27 | Buy |
| 50-day EMA: | 45.2 | Sell |
| 200-day EMA: | 54.72 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.12 | Buy |
| 20-day SMA: | 24.89 | Buy |
| 50-day SMA: | 22.96 | Buy |
| 200-day SMA: | 21.92 | Buy |
| 8-day EMA: | 25.14 | Buy |
| 20-day EMA: | 24.54 | Buy |
| 50-day EMA: | 23.77 | Buy |
| 200-day EMA: | 24.35 | Buy |
LyondellBasell Industries NV Earnings Growth & LYB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $1.39 per share.
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.44 per share, and an increase next year of $0.91 per share.
LyondellBasell Industries NV Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||